H. Gary Schoch

3.8k total citations · 2 hit papers
25 papers, 2.7k citations indexed

About

H. Gary Schoch is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, H. Gary Schoch has authored 25 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 9 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in H. Gary Schoch's work include Hematopoietic Stem Cell Transplantation (17 papers), Neutropenia and Cancer Infections (5 papers) and Antifungal resistance and susceptibility (4 papers). H. Gary Schoch is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Neutropenia and Cancer Infections (5 papers) and Antifungal resistance and susceptibility (4 papers). H. Gary Schoch collaborates with scholars based in United States, South Africa and France. H. Gary Schoch's co-authors include Raleigh A. Bowden, Monica A. Slavin, George B. McDonald, Joel D. Meyers, Marcia J. Levenstein, R. Adams, Mary E.D. Flowers, Rainer Storb, Ted Gooley and Lawrence Corey and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

H. Gary Schoch

25 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Solid Cancers after Bone Marrow Transplantation

1997 677 citations Rochelle E. Curtis, Philip A. Rowlings et al. New England Journal of Medicine profile →
Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study

1995 611 citations Monica A. Slavin, R. Adams et al. The Journal of Infectious Diseases profile →

Peers

H. Gary Schoch

HEMAT

EPIDE

ONCOL

PHEOH

Dick Stockelberg Sweden

U. Jehn Germany

Stefano Tarantolo United States

A. W. Dekker Netherlands

Liat Vidal Israel

Anna Candoni Italy

Winston G. Ho United States

Nelson Spector Brazil

Jan Styczyński Poland

Carole B. Miller United States

Dick Stockelberg Sweden

H. Gary Schoch

1.7k ×1.5

HEMAT

1.2k ×1.2

EPIDE

763 ×0.9

ONCOL

1.1k ×1.3

644 ×1.6

PHEOH

Citations per year, relative to H. Gary Schoch H. Gary Schoch (= 1×) peers Dick Stockelberg

Countries citing papers authored by H. Gary Schoch

Since Specialization

Citations

This map shows the geographic impact of H. Gary Schoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Gary Schoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Gary Schoch more than expected).

Fields of papers citing papers by H. Gary Schoch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Gary Schoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Gary Schoch. The network helps show where H. Gary Schoch may publish in the future.

Co-authorship network of co-authors of H. Gary Schoch

This figure shows the co-authorship network connecting the top 25 collaborators of H. Gary Schoch. A scholar is included among the top collaborators of H. Gary Schoch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Gary Schoch. H. Gary Schoch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCune, Jeannine S., Sandi L. Navarro, Linda J. Risler, et al.. (2023). The presence of busulfan metabolites and pharmacometabolomics in plasma drawn immediately before allograft infusion in hematopoietic cell transplant recipients. Clinical and Translational Science. 16(12). 2577–2590. 2 indexed citations

Bezerra, Evandro D., Linde M. Morsink, Megan Othus, et al.. (2019). Comparative Analysis of Total Body Irradiation (TBI)-Based and Non-TBI-Based Myeloablative Conditioning for Acute Myeloid Leukemia in Remission with and without Measurable Residual Disease. Blood. 134(Supplement_1). 321–321. 1 indexed citations

Rezvani, Andrew R., Barry E. Storer, Katherine A. Guthrie, et al.. (2014). Impact of Donor Age on Outcome after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(1). 105–112. 42 indexed citations

Chien, Jason W., Miwa Sakai, Ted Gooley, H. Gary Schoch, & GB McDonald. (2009). Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials. Bone Marrow Transplantation. 45(2). 317–324. 6 indexed citations

Sakai, Miwa, et al.. (2009). Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome. Bone Marrow Transplantation. 44(7). 441–447. 32 indexed citations

Woodahl, Erica L., Sangeeta Hingorani, Katherine A. Guthrie, et al.. (2007). Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation. The Pharmacogenomics Journal. 8(4). 248–255. 14 indexed citations

McCune, Jeannine S., Ami Batchelder, H. Joachim Deeg, et al.. (2007). Cyclophosphamide following Targeted Oral Busulfan as Conditioning for Hematopoietic Cell Transplantation: Pharmacokinetics, Liver Toxicity, and Mortality. Biology of Blood and Marrow Transplantation. 13(7). 853–862. 73 indexed citations

Malone, Frances R., Wendy M. Leisenring, Barry E. Storer, et al.. (2007). Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant. Bone Marrow Transplantation. 40(8). 765–772. 28 indexed citations

Holmberg, Leona, Kaoru Kikuchi, Ted Gooley, et al.. (2006). Gastrointestinal Graft-versus-Host Disease in Recipients of Autologous Hematopoietic Stem Cells: Incidence, Risk Factors, and Outcome. Biology of Blood and Marrow Transplantation. 12(2). 226–234. 47 indexed citations

10.

Gooley, Ted, Pankaj Rajvanshi, H. Gary Schoch, & George B. McDonald. (2005). Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation†. Hepatology. 41(2). 345–352. 44 indexed citations

11.

Hogan, William J., Michael B. Maris, Barry E. Storer, et al.. (2003). Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. Blood. 103(1). 78–84. 95 indexed citations

12.

Marr, Kieren A., Kristy Seidel, Monica A. Slavin, et al.. (2000). Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood. 96(6). 2055–2061. 25 indexed citations

13.

Matute‐Bello, Gustavo, et al.. (1998). Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation. Bone Marrow Transplantation. 21(11). 1125–1130. 29 indexed citations

14.

Curtis, Rochelle E., Philip A. Rowlings, H. Joachim Deeg, et al.. (1997). Solid Cancers after Bone Marrow Transplantation. New England Journal of Medicine. 336(13). 897–904. 677 indexed citations breakdown →

15.

Gooley, Ted, H. Gary Schoch, David Myerson, et al.. (1997). Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis. Bone Marrow Transplantation. 20(12). 1081–1086. 32 indexed citations

16.

Brawner, D L, Raleigh A. Bowden, Wally Meyer, et al.. (1995). Fungal Liver Infection in Marrow Transplant Recipients: Prevalence at Autopsy, Predisposing Factors, and Clinical Features. Clinical Infectious Diseases. 20(4). 801–811. 54 indexed citations

17.

Slavin, Monica A., R. Adams, Marcia J. Levenstein, et al.. (1995). Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study. The Journal of Infectious Diseases. 171(6). 1545–1552. 611 indexed citations breakdown →

18.

Mickelson, E.M., P Beatty, D. B. Amos, et al.. (1992). Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.. PubMed. 9(2). 87–90. 28 indexed citations

19.

Bearman, SI, F R Appelbaum, Anna Bäck, et al.. (1989). Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.. Journal of Clinical Oncology. 7(9). 1288–1294. 99 indexed citations

20.

Schoch, H. Gary. (1954). [Silicosis and lung cancer; based on the case histories of the Swiss Accident Insurance Company from 1932-1953].. PubMed. 47(3). 184–95; concl. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact